Latest It Distribution News

Algorae Pharmaceuticals has secured a key Licence & Supply Agreement with Cadila Pharmaceuticals to commercialise two generic cardiovascular and metabolic medicines in Australia and New Zealand, broadening its therapeutic reach beyond oncology.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

Catalina Resources has appointed Core Drilling Pty Ltd to commence a 3,000-metre RC drilling program at its Breakaway Dam Copper VMS Project, aiming to expand on recent promising copper sulphide discoveries in Western Australia.

CAR Group Limited has announced a fully paid ordinary dividend of AUD 0.425 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan (DRP) with no discount.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

Credit stocks swung hard, with Credit Corp sliding despite steady profits and a busy acquisition agenda. Payments and capital management stories did the heavy lifting elsewhere, from Klevo’s Mastercard milestones to Regal’s buy-back.

A single drill program in WA delivered a once-a-year spike, while several small caps fell hard after reopening with price gaps. This week also saw big money raised for gold and uranium builds, and a run of resource upgrades across critical minerals.

A single diagnostics update sparked a breakout week, while a handful of biotech names sold off hard despite busy newsflow. Capital raisings, takeover steps and US market pushes kept healthcare in motion heading into mid-February milestones.

Nimy Resources has dispatched its first shipment of high-grade gallium mineralised test material from Western Australia to the United States, marking a key step in developing a secure Western supply chain for this critical mineral. The collaboration with M2i Global aims to identify optimal processing routes to support U.S. defence and semiconductor industries.

Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.

Murray Cod Australia announces the departure of CEO Ross Anderson, with interim leadership stepping in as the company searches for a new chief executive.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.